Friday, September 30, 2011
Sunday, September 25, 2011
This article, found in The Lancet, discusses poverty’s potential role in a future pandemic and what can be done to prevent a country’s economic situation from determining whether one dies or not. According to Neil Ferguson, the author of this article, “a novel 1918-like virus would cause a death toll of 62 million people worldwide, 96% of whom would be in the developing world.” Despite all of the advances that we have made since 1918, people in the developing world are unlikely to benefit from them, in part because they do not have access to them. In addition, malnutrition and comorbidities such as hiv and malaria may reduce the effectiveness of those medical advancements. In order to deal with these problems, Neil Ferguson suggests that all countries work to increase access to vaccines and drugs to individuals and countries who may not be able to provide for themselves. He also proposes the idea of increased surveillance in order to prevent the spread of any disease and to attract the help of more economically developed countries.
Here’s the link to the article:
Saturday, September 24, 2011
Check it out: http://www.sciencedaily.com/releases/2010/09/100928153809.htm
Friday, September 23, 2011
Taken from http://downloads.hindawi.com/journals/ecam/2011/252501.pdf, Han, from the Shandong University of Traditional Chinese Medicine, and Guo from the Chinese Academy of Sciences have hypothesized that there are several biologically active compounds in mushrooms (including beta-D-glucans and other polysaccharides) that are able to boost the immune system, which can increase the chance of survival in response to the H1N1 virus.
Their hypothesis is backed by several previous studies done on mice, showing the effective response elicited by mushroom extracted compounds against viruses. For example, active hexose is a compound in mushrooms that has been reported to boost natural killer activity. Other compounds such as ganodermadiol, lucidadiol and applanoxidic acid G have been shown to be effective against influenza type A viruses and the herpes simplex virus type 1.
I can't wait to see the results on this study!